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Background: Hepatitis C virus (HCV) is highly infectious pathogen which is responsible for causing Hepatitis around
200 million individuals worldwide. In Pakistan, 4.7% of HCV prevalence has been reported and HCV genotype 3a has
been found to be the major source of infection in Pakistan but still there is lack of information on distribution of
HCV genotypes and viral load in various geographical regions of Pakistan. Therefore, current study was designed to
determine distribution of HCV genotypes as well viral load in different areas of Punjab province of Pakistan.
Findings: A total of 995 serum samples were taken from those individuals in which antibodies against HCV were
detected through ELISA, from different regions of Punjab i.e. Lahore 317(31.85%), Faisalabad 70(7.03%), Gujranwala
129(12.96%), Gujrat 106(10.65%), Sialkot 94(9.44%), Sargodha 60(6.03%), Mandibaha-ud-din 135(13.56%), Jhang 86
(8.64%). Qualitative PCR was performed to determine viral load and genotyping was performed using Nested PCR.
Chi-square test was used to determine the age and sex-wise prevalence of HCV. Out of 995 samples, 888 samples
were found positive for HCV RNA. In all regions, genotype 3a showed highest prevalence (82.81%) followed by
genotype 1 (3.41%), mixed genotypes (2.41%), genotype 2 (0.50%), genotype 5 (0.1%) and unclassified genotypes
(10.75%). Viral load in 29.5% patients infected with genotype 3a was less than 600,000 IU/mL, while it was between
600,000-800,000 IU/mL in 27.9% patients and 25.22% patients had more than 800,000 IU/mL viral load.
Conclusion: HCV genotype 3a is the most prevalent genotype in various regions of Punjab. Viral load of HCV
patients in these different regions of Punjab are reported for the first time. Moreover, based upon these results the
Patients having viral load below 800,000 IU/mL would be expected to show better response of anti-HCV therapy.
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Background
Hepatitis C virus (HCV) is a globally distributed human
pathogen that has affected around 200 million individuals. It
is a principle cause of chronic liver disorders including liver
cirrhosis, liver fibrosis and hepatocellular carcinoma. HCV
is a positive-sense single-stranded RNA virus belonging to
genus Hepacivirus, the member of Flaviviridae family, with
characteristic of genetic heterogeneity [1]. HCV is an envel-
oped virus that contains small genome of about 9,600 nucle-
otides [2]. Due to genetic variability, there are 6 extensively
identified genotypes and each genotype has difference of
30%-35% in its nucleotide site sequence from others [1,3].* Correspondence: suliman_afridi16@yahoo.com
†Equal contributors
1Quality Operations Laboratory, UVAS, Lahore 54000, Pakistan
Full list of author information is available at the end of the article
© 2014 Afridi et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
waiver (http://creativecommons.org/publicdom
stated.Each genotype contains several subtypes having more than
75% nucleotide sequence similarity among them [4]. In
comparison, more than 95% of the virions infecting one
patient are similar [5]. HCV genotype/subtype identification
is crucial for clinicians when it comes to choosing a therapy
because these genotypes have been reported to exhibit
different responses to prescribed anti-viral therapies and
require varying duration and doses of therapy [6]. The
transmission of HCV is on average six times more likely
than HIV after a percutaneous exposure [7]. The distribu-
tion of virus is worldwide but some strains are particularly
detected in specific geographical regions. HCV genotypes
1a, 1b, and 3a are prevalent “epidemic” strains all over the
world [7]. During 20th century above mentioned strains
spread quickly, probably through infected blood-products
and use of injectable drugs, and possess comparatively less
genetic variations. On the other hand, other HCV strainstd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
Table 1 HCV prevalence in different regions of Punjab province
Genotype Sub-type Districts*
Lahore Faisalabad Gujranwala Gujrat Sialkot Sargodha Mandi Baha-ud-Din Jhang
1 1a 9* (2.83%)# 1(1.42%) 4(3.10%) 2(1.88%) 1(1.06%) 2(3.33%) 5(3.70%) 2(2.32%)
1b 2(0.63%) 1(1.42%) 1(0.77%) 0 1(1.06%) 1(1.66%) 1(0.74%) 1(1.16%)
2 2a 0 1(1.42%) 0 0 0 1(1.66%) 0 1(1.16%)
2b 0 1(1.42%) 1(0.77%) 0 0 0 0 0
3 3a 240(75.70%) 60(85.71%) 107(82.94%) 98(92.45%) 76(80.85%) 46(76.66%) 119(88.14%) 76(88.37%)
3b 0 0 1(0.77%) 0 0 0 0 1(1.16%)
5 5a 0 0 0 0 1(1.06%) 0 0 0
Mixed 4 (1.26%) 0 6(4.65%) 3(2.83%) 2(2.12%) 3(5%) 4(2.96%) 2(2.32%)
Not detected 62(19.55%) 6(8.57%) 9(6.97%) 3(2.83%) 11(11.70%) 7(11.66%) 6(4.44%) 3(3.48%)
Total 317(31.85%) 70(7.03%) 129(12.96%) 106(10.65%) 92(9.24%) 60(6.03%) 135(13.56%) 86(8.64%)
*Number of samples belonging to respective sub-type.














Table 2 HCV viral load in patients from different genders




value**< 600,000 600,000-800,000 > 800,000
Genotype 3 294* 278 252 0.067
Other genotypes 71 42 58
Male 199 159 153 0.314
Female 166 161 157
Lahore
Genotype 3 79 87 74 0.112
Other genotypes 24 20 33
Faisalabad
Genotype 3 24 19 17 0.260
Other 4 1 5
Gujranwala
Genotype 3 40 31 37 0.932
Other 7 6 8
Gujrat
Genotype 3 31 41 26 0.527
Other 4 2 2
Sargodha
Genotype 3 13 18 15 0.397
Other genotypes 4 3 7
Silakot
Genotype 3 31 23 22 0.915
Other 7 4 5
Jhang
Genotype 3 30 25 22 0.821
Other 4 2 3
Mandi Baha ud Din
Genotype 3 53 36 30 0.278
Other 10 2 4
*Number of samples belonging to respective sub-type and under respective
viral load.
**Chi Square statistics used to analyse both genotypes and viral loads.
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specific geographical areas [8]. Genotypes 1, 2 and 4 are
confined to certain regions of Africa and the Middle East,
whereas genotypes 3 and 6, divergent endemic strains, are
detected in numerous localities of Southeast Asia [9]. The
present study was designed to find different genotypes and
viral load of HCV in different districts of Punjab province
of Pakistan.
Methods
A total of 995 blood samples were collected from those
individuals in which antibodies against HCV were detected
through ELISA, to find out their viral load and genotyping
situated in different districts/ towns of Punjab, Pakistan.
In order to fulfill the legal and ethical requirements, this
study got approval by Ethical Committee Bacteriologist to
Government of Punjab health department (No. 1029/
Bact.). Written consent was taken to record the age,
district, and phone and complete address of the patients.
Each blood sample, subjected to get serum, was cen-
trifuged at 3000 RPM for 5 min. Serum obtained were
labeled and stored at − 20°C till extractions begin.
Extraction of RNA was done using Qiagen kit (Invitro-
gen, Corp., California; USA). The cDNA of 5’NCR was
synthesized using 100 units of Moloney Murine Leukemia
Virus (MMLV) reverse transcriptase enzyme (RTEs)
(Invitrogen, Corp., California USA) with 5 pM of outer
antisense primer. HCV RNA was quantified as the
protocol described by Ali et al., 2011 [10]. Two rounds
of PCR amplifications were done (first round PCR and
Nested PCR) with two units of Taq DNA polymerase
enzyme (Invitrogen, Corp., California USA) in a volume
of 20 μl reaction mix. Different allele-specific primers
were used for the detection of HCV genotypes [10].
Chi-square statistics using SPSS version 16.0 (IBM Cor-
poration 2008) was used to analyse the genotype preva-
lence and distribution among genders and all age groups.
P value < 0.05 was considered significant.
Results
Different HCV prevalent genotypes and viral load between
both genders in different geographical regions of Punjab
province is shown in Table 1 and Table 2. Of 995 samples,
511 (51%) samples from males and 484(49%) from females
were declared as HCV positive that showed nearly equal
representation between both genders. Among these 995
samples, 888 (89.25%) samples were detected on the basis
of specific PCR fragment while 107 (10.75%) samples
remained unable to demonstrate a specific genotypic
band. Genotype 3(82.81%) was highest in both genders
followed by genotype 1 (3.41%), mixed genotypes (2.41%),
genotype 2 (0.50%), genotype 5 (0.1%) and unclassified
genotypes (10.75%), (Figure 1). Among the sub-genotypes,
the most detected sub-genotype in males was 3a (80.62%)followed by 1a subtype (3.13%) and 1b subtype (0.98%).
Other less frequent subtypes were 2a (0.39%), 3b (0.39%),
2b (0.19%) and 5a (0.19%). In females, most frequent sub-
genotypes were 3a (84.7%), 1a (2.06%), 1b (0.61%), 2a
(0.20%) and 2b (0.20%). On the other hand sub-genotypes
like 3b and 5a were absent in females (Figure 1).
On basis of age, different groups of genotyped samples
were formed such as 10–20 years, 21–30 years, 31–
40 years, 41–50 years, 51–60 years and above 60 years.
The overall percentage of positive HCV samples in all
age groups was higher in males as compare to females
except in the age group 41 – 50 years (Figure 2). The
distribution of genotypes in all age group categories was
also observed. Genotype 3a was highest in all age groups












Figure 1 Prevalence of HCV genotypes in different genders.
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genotypes (2.41%).
Among the total HCV positive samples, 317(31.85%)
were belonged to Lahore. Among these, 9(2.83%) were
genotype 1a, 2(0.63%) were genotype 1b, 240(75.70%) were
genotype 3a whereas 62(19.55%) were un-typeable and
genotype 4 (1.26%) was with mixed genotypes. The HCV
positive patients of Faisalabad were 70(7.03%). Among
these, 1(1.42%) belonged to 1a, 1(1.42%) was 1b, 1(1.42%)
was 2a, 1(1.42%) was 2b, 60(85.71%) were 3a and 6(8.57%)
were un-typeable genotypes. Among the total of 129
(12.96%) samples from Gujranwala, 4(3.10%) were 1a, 1
(0.77%) was 1b, 1(0.77%) belonged to 2b, 107(82.94%)
were 3a, 1(0.77%) was 3b, 9(6.97%) were untypeable geno-
types and 6(4.65%) were with mixed genotypes (Table 1).
Prevalence of HCV genotypes among 106(10.65%) posi-
tive patients of Gujrat was 2(1.88%) patients were with 1a,
98(92.45%) were with 3a, 3(2.83%) were with mixed infec-
tion and 3(2.83%) were with unclassified HCV band. Total
94(9.44%) patients were genotyped from Sialkot in which
1(1.06%) was 1a, 1(1.06%) were 1b, 1(1.06%) was 2a, 76
(80.85%) were 3a, 1(1.06%) was 3b, 1(1.06%) was 5a
genotype, 2(2.12%) were mixed genotypes and 11(11.70%)
















Figure 2 Prevalence of HCV in different age groups.samples belonged to Sargodha were 60(6.03%). Among
these, 2(3.33%) were 1a, 1(1.66%) was 1b, 1(1.66%) was 2a,
46(76.66%) were 3a, 3(5%) were mixed and 7(11.66%) were
untypeable genotypes. Total HCV samples belonged to
Mandi Baha ud Din were 135(13.56%). Among these, 5
(3.70%) were 1a, 1(0.74%) was 1b, 119(88.14%) were 3a
and 4(2.96%) were mixed gentoypes. Six 6(4.44%) were
untypeable genotypes. The Genotyped samples that
belonged to Jhang were 86(8.64%). Among these, 2(2.32%)
were 1a, 1(1.16%) were 1b, 1(1.16%) were 2a, 76(88.37%)
were 3a, 1(1.16%) was 3b, 2(2.32%) were mixed genotypes
and 3(3.48%) were untypeable genotypes (Table 1).
Discussion
In this study, we demonstrated the HCV genotype distri-
bution in different categories and the existence of associ-
ation between genotypes and gender. The current study
evidently depicts that there is no significant difference
between gender and HCV genotypes because HCV geno-
types were distributed with equal probability between
the both sexes. These results are in accordance with
many preceding studies showing no statistical difference
in gender with respect to variation among genotypes
in Pakistan [11-13]. Current study contradicts with a
Libyan study in which HCV genotype 1 possessed signifi-
cant association with males whereas genotype 4 showed
high frequency in females [14]. The results of this study
have shown that high prevalence of HCV infection was
found at age of <50 years. These findings are in partial
agreement with the former studies [10,11,15] that noted
the high prevalence in age group of ≤40 years [13,16].
It has been observed that HCV genotype 3a is highly
prevalent in Pakistan [10-13,15-17], in contrast, a study
has revealed the results from Balochistan where the 1a has
higher frequency [7]. Current study revealed that genotype
3a is most frequent and common followed by genotype 1a
in HCV infected patients. The HCV genotype distribution
pattern is similar to the reported studies from neighbouring
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than others [16]. Current study has also detected a rare
genotype 5a, which is less reported and less frequent. This
finding is in agreement with the previous studies that
showed the presence of 5a but rare status of this genotype
[7,12,15]. These findings are in contradiction with some
studies that have shown the partial absent status of geno-
types 4, 5, 6 [10].
In this study, we have determined the viral load with
respect to genotypes in different districts and gender
as showed in Table 2. On the basis of specified levels,
we categorized viral load into three classes i.e. low
level (< 60, 0000 IU/ml), intermediate level (60,0000-
80,0000 IU/ml) and high level (> 80,0000 IU/ml). The
results of our study are in line with previous findings
that there are no significant differences in HCV RNA
levels of both genders (Table 2) [18]. We have observed
that the viral load in 29% patients was less than
600,000 IU/mL, while it was between 600,000-800,000 IU/
mL in 27.83% patients and 25.22% patients had more than
800,000 IU/mL viral load. It is already established that
under therapeutic considerations sustained virological re-
sponse (SVR) can be easily attained in genotype 3 HCV
patients with low viral load (<600,000-800,000 IU/ml)
when compared with patients having high viral load
(>600000-800000 IU/mL) [19,20]. HCV patients consid-
ered potential candidates for Interferon (IFN) therapy.
But most of people in Pakistan deprived of this therapy
because of high cost, little awareness among common
people and lack of genotyping information in many
geographical regions. Limited data regarding treatment
of HCV is available in Pakistan and no documented
evidence has been found on the percentage of patient
treated with IFN. So, based on this study a well-planned
treatment protocol can be conducted and record of IFN
treatment therapy can be carried out.
Conclusion
Current findings conclude that multiple genotypes of
HCV exist in Pakistan in which 3a and 1a are more
common. A better understanding of the impact of high
HCV RNA levels during the progression of HCV infection
is needed, in order to find patients who would get the
most benefits from treatment against HCV.
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